2010
DOI: 10.1016/j.npep.2009.09.005
|View full text |Cite
|
Sign up to set email alerts
|

The regulatory role of neurotensin on the hypothalamic–anterior pituitary axons: Emphasis on the control of thyroid-related functions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
4
4
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 81 publications
0
11
0
Order By: Relevance
“…The pattern of changes we measured in D2 mRNA was intriguing but didn't reach statistical significance; it does however warrant future investigation. Also, our list of candidates was certainly not exhaustive; other neuropeptides and neurosystems have been shown to impact the HPT axis (Lechan and Fekete, 2006, Nillni, 2010, Stolakis et al, 2010). TRH activity could also be decreased without accompanying changes in mRNA levels; for example changes in processing of the TRH molecule may alter its bioactivity (Perello et al, 2006) or the TRH specific peptidase PP II (Heuer et al, 1998) located within the tanycytes in the medial-basal hypothalamus (Sanchez et al, 2009) may also alter TRH bioactivity.…”
Section: Discussionmentioning
confidence: 99%
“…The pattern of changes we measured in D2 mRNA was intriguing but didn't reach statistical significance; it does however warrant future investigation. Also, our list of candidates was certainly not exhaustive; other neuropeptides and neurosystems have been shown to impact the HPT axis (Lechan and Fekete, 2006, Nillni, 2010, Stolakis et al, 2010). TRH activity could also be decreased without accompanying changes in mRNA levels; for example changes in processing of the TRH molecule may alter its bioactivity (Perello et al, 2006) or the TRH specific peptidase PP II (Heuer et al, 1998) located within the tanycytes in the medial-basal hypothalamus (Sanchez et al, 2009) may also alter TRH bioactivity.…”
Section: Discussionmentioning
confidence: 99%
“…NT is expressed in many tissues both centrally and peripherally. In the CNS, NT is widely expressed at high levels in the amygdala, hypothalamus, SN and VTA, and at lower levels in areas such as the hippocampus, cortex and striatum (Manberg et al, 1982; Stolakis et al, 2010; Boules et al, 2013). Thus, NT is found within corticostriatal-limbic circuitry where it acts as a neurotransmitter and neuromodulator (Binder et al, 2001a; Ferraro et al, 2008; Petkova-Kirova et al, 2008a,b).…”
Section: Neurotensinmentioning
confidence: 99%
“…Centrally, NT has a wide range of actions. NT plays a role in opioid-independent antinociception (Kleczkowska and Lipkowski, 2013), hypothermia (Bissette et al, 1976), blood pressure (Sumners et al, 1982), anterior pituitary hormone secretion (Rostene and Alexander, 1997; Stolakis et al, 2010), food intake (Cooke et al, 2009), and sleep (Fitzpatrick et al, 2012). NT also possesses antipsychotic-like effects, which are largely attributed to NT-mediated regulation of dopaminergic signaling (Binder et al, 2001b; Kinkead and Nemeroff, 2004, 2006; Vadnie et al, 2014).…”
Section: Neurotensinmentioning
confidence: 99%
“…The role of neurotensin in the hypothalamic-pituitary axis has been extensively reviewed by Rostene and Alexander [14], and a recent review by Stolakis et al [15] emphasized the involvement of neurotensin in centrally controlled thyroid-related functions. Dungan Lemko et al [16] recently investigated the role of neurotensin in the gonadotropin-releasing hormone (GnRH)-induced luteinizing hormone (LH) surge required for ovulation, in which the presence of estrogen-receptors on neurotensinergic inputs to the hypothalamus has been suggested as a link in the positive feedback of estradiol (E2) on GnRH release [17,18].…”
Section: Neurotensin and Other Neural Pathwaysmentioning
confidence: 99%